{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:47:55Z","timestamp":1773269275868,"version":"3.50.1"},"reference-count":54,"publisher":"Baishideng Publishing Group Inc.","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJH"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4254\/wjh.v7.i24.2503","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T02:02:46Z","timestamp":1445565766000},"page":"2503","source":"Crossref","is-referenced-by-count":104,"title":["Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine"],"prefix":"10.4254","volume":"7","author":[{"given":"Saqib","family":"Walayat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"World Health Organization. Hepatitis B 2002; Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/handle\/10665\/67746\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/apps.who.int\/iris\/handle\/10665\/67746<\/ext-link>."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24804"},{"key":"ref3","unstructured":"FAQs for Health Professionals: Hepatitis B Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/hepatitis\/HBV\/HBVfaq.htm#overview\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.cdc.gov\/hepatitis\/HBV\/HBVfaq.htm#overview<\/ext-link>."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2003.00487.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)80050-N"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/9783-642-69159-1_2"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj009"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp041507"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.4.992"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol 1995;142:331-341.","DOI":"10.1093\/oxfordjournals.aje.a117639"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"McQuillan GM, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health 1999;89:14-18.","DOI":"10.2105\/AJPH.89.1.14"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR. Human hepatitis B vaccine from recombinant yeast. Nature 1984;307:178-180.","DOI":"10.1038\/307178a0"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22975"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj010"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Vora KA, Tumas-Brundage K, Manser T. Contrasting the in situ behavior of a memory B cell clone during primary and secondary immune responses. J Immunol 1999;163:4315-4327.","DOI":"10.4049\/jimmunol.163.8.4315"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.08.058"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu867"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00405-X"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit684"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20716"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.531"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Denis F, Mounier M, Hessel L, Michel JP, Gualde N, Dubois F, Barin F, Goudeau A. Hepatitis-B vaccination in the elderly. J Infect Dis 1984;149:1019.","DOI":"10.1093\/infdis\/149.6.1019"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/0264410X(94)90313-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1086\/433180"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.040"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Mattos AA, Gomes EB, Tovo CV, Alexandre CO, Remi\u00e3o JO. Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus. Arq Gastroenterol 2004;41:180-184.","DOI":"10.1590\/S0004-28032004000300008"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.05.071"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.08.019"},{"key":"ref29","unstructured":"Agarwal SK, Irshad M, Dash SC. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure. J Assoc Physicians India 1999;47:183-185."},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Bonazzi PR, Bacchella T, Freitas AC, Osaki KT, Lopes MH, Freire MP, Machado MC, Abdala E. Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. Braz J Infect Dis 2008;12:306-309.","DOI":"10.1590\/S1413-86702008000400009"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510310134"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.15720241.2002.05482.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.01.043"},{"key":"ref34","unstructured":"Jakob T, Udey MC. Epidermal Langerhans cells: from neurons to nature&rsquo;s adjuvants. Adv Dermatol 1999;14:209-258; discussion 259."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8561(03)00094-8"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Rahman F, Dahmen A, Herzog-Hauff S, B&ouml;cher WO, Galle PR, L&ouml;hr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000;31:521-527.","DOI":"10.1002\/hep.510310237"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-011-1996-0"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.03.010"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wahl M, Hermodsson S. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response. Scand J Infect Dis 1987;19:617-621.","DOI":"10.3109\/00365548709117195"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.13652893.1996.tb00079.x"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.3.678"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.01.007"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7077.329"},{"key":"ref44","unstructured":"Haubitz M, Ehlerding G, Beigel A, Heuer U, Hemmerling AE, Thoma HA. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency. Clin Nephrol 1996;45:180-182."},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00397-3"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.077"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1586\/erv.10.162"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.07.011"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.08.003"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2006.09.010"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2174\/157018007782794545"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.074"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1086\/589722"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Leroux-Roels G, Haelterman E, Maes C, Levy J, De Boever F, Licini L, David MP, Dobbelaere K, Descamps D. Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16\/18 AS04-adjuvanted cervical cancer vaccine. Clin Vaccine Immunol 2011;18:1510-1518.","DOI":"10.1128\/CVI.00539-10"}],"container-title":["World Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i24\/2503.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:20:03Z","timestamp":1692112803000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1948-5182\/full\/v7\/i24\/2503.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":54,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.4254\/wjh.v7.i24.2503","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}